Engineered Embryonic Stem Cells for Regnerative Medicine

Konferenz: VDE-Kongress 2006 - Innovations for Europe - Fachtagungsberichte der ITG/BMBF - GMM - ETG - GMA - DGBMT
23.10.2006 - 25.10.2006 in Aachen, Germany

Tagungsband: VDE-Kongress 2006

Seiten: 4Sprache: EnglischTyp: PDF

Persönliche VDE-Mitglieder erhalten auf diesen Artikel 10% Rabatt

Hescheler, J. (Institut für Neurophysiologie, Robert-Koch-Str. 39, 50931 Köln, Germany)

Adult, fetal as well as embryonic stem cells are currently one of the most promising subjects of biomedical research. Besides advancing the basic understanding of human development and cellular differentiation processes, stem cells hold the unique potential for novel therapies of degenerative diseases such as ischemia of the heart, Parkinson’s diabetes, and certain tumours. In particular, because of their ability to reproduce the embryological differentiation of nearly all different cellular phenotypes, the pluripotent embryonic stem (ES) cells represent an ideal tool to study processes of embryogenesis under in vitro conditions, the signalling cascades and genes involved in the functional development (functional genomics) as well as to provide a new source for building up physiological screening systems and for usage in cellular replacement therapies.